Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis
Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future cardiovascular disease (CVD). The predictive strength of FMD in CVD patients compared to populations not diagnosed for CVD warrants further investigation. We syste...
Saved in:
| Published in | International journal of cardiology Vol. 168; no. 1; pp. 344 - 351 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Shannon
Elsevier Ireland Ltd
20.09.2013
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0167-5273 1874-1754 1874-1754 |
| DOI | 10.1016/j.ijcard.2012.09.047 |
Cover
| Abstract | Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future cardiovascular disease (CVD). The predictive strength of FMD in CVD patients compared to populations not diagnosed for CVD warrants further investigation. We systematically reviewed prospective studies that investigated the association between brachial FMD and future cardiovascular events, with particular focus on the role of underlying health status.
To obtain eligible studies, several literature databases were systematically searched through March 2011. Pooled overall risk estimates were calculated separately for continuous risk estimates for CVD (per 1% higher FMD) and for categorical risk estimates for CVD (having high vs. low FMD), based on random-effects models.
A total of 23 studies including 14,753 subjects were eligible for inclusion in the meta-analysis. For studies reporting continuous risk estimates, the pooled overall CVD risk was 0.92 (95%CI: 0.88; 0.95) per 1% higher FMD. The observed association seemed stronger (P-value<0.01) in diseased populations than in asymptomatic populations (0.87 (95%CI: 0.83; 0.92) and 0.96 (95%CI: 0.92; 1.00) per 1% higher FMD, respectively). For studies reporting categorical risk estimates, the pooled overall CVD risk for high vs. low FMD was similar in both types of populations, on average 0.49 (95%CI: 0.39; 0.62).
Our findings show that brachial FMD is inversely associated with future CVD events, with some indications for a stronger relation in diseased populations. Endothelial dysfunction may be considered relevant for classifying subjects in terms of CVD risk. |
|---|---|
| AbstractList | Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future cardiovascular disease (CVD). The predictive strength of FMD in CVD patients compared to populations not diagnosed for CVD warrants further investigation. We systematically reviewed prospective studies that investigated the association between brachial FMD and future cardiovascular events, with particular focus on the role of underlying health status.BACKGROUNDFlow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future cardiovascular disease (CVD). The predictive strength of FMD in CVD patients compared to populations not diagnosed for CVD warrants further investigation. We systematically reviewed prospective studies that investigated the association between brachial FMD and future cardiovascular events, with particular focus on the role of underlying health status.To obtain eligible studies, several literature databases were systematically searched through March 2011. Pooled overall risk estimates were calculated separately for continuous risk estimates for CVD (per 1% higher FMD) and for categorical risk estimates for CVD (having high vs. low FMD), based on random-effects models.METHODSTo obtain eligible studies, several literature databases were systematically searched through March 2011. Pooled overall risk estimates were calculated separately for continuous risk estimates for CVD (per 1% higher FMD) and for categorical risk estimates for CVD (having high vs. low FMD), based on random-effects models.A total of 23 studies including 14,753 subjects were eligible for inclusion in the meta-analysis. For studies reporting continuous risk estimates, the pooled overall CVD risk was 0.92 (95%CI: 0.88; 0.95) per 1% higher FMD. The observed association seemed stronger (P-value<0.01) in diseased populations than in asymptomatic populations (0.87 (95%CI: 0.83; 0.92) and 0.96 (95%CI: 0.92; 1.00) per 1% higher FMD, respectively). For studies reporting categorical risk estimates, the pooled overall CVD risk for high vs. low FMD was similar in both types of populations, on average 0.49 (95%CI: 0.39; 0.62).RESULTSA total of 23 studies including 14,753 subjects were eligible for inclusion in the meta-analysis. For studies reporting continuous risk estimates, the pooled overall CVD risk was 0.92 (95%CI: 0.88; 0.95) per 1% higher FMD. The observed association seemed stronger (P-value<0.01) in diseased populations than in asymptomatic populations (0.87 (95%CI: 0.83; 0.92) and 0.96 (95%CI: 0.92; 1.00) per 1% higher FMD, respectively). For studies reporting categorical risk estimates, the pooled overall CVD risk for high vs. low FMD was similar in both types of populations, on average 0.49 (95%CI: 0.39; 0.62).Our findings show that brachial FMD is inversely associated with future CVD events, with some indications for a stronger relation in diseased populations. Endothelial dysfunction may be considered relevant for classifying subjects in terms of CVD risk.CONCLUSIONSOur findings show that brachial FMD is inversely associated with future CVD events, with some indications for a stronger relation in diseased populations. Endothelial dysfunction may be considered relevant for classifying subjects in terms of CVD risk. Abstract Background Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future cardiovascular disease (CVD). The predictive strength of FMD in CVD patients compared to populations not diagnosed for CVD warrants further investigation. We systematically reviewed prospective studies that investigated the association between brachial FMD and future cardiovascular events, with particular focus on the role of underlying health status. Methods To obtain eligible studies, several literature databases were systematically searched through March 2011. Pooled overall risk estimates were calculated separately for continuous risk estimates for CVD (per 1% higher FMD) and for categorical risk estimates for CVD (having high vs. low FMD), based on random-effects models. Results A total of 23 studies including 14,753 subjects were eligible for inclusion in the meta-analysis. For studies reporting continuous risk estimates, the pooled overall CVD risk was 0.92 (95%CI: 0.88; 0.95) per 1% higher FMD. The observed association seemed stronger (P-value < 0.01) in diseased populations than in asymptomatic populations (0.87 (95%CI: 0.83; 0.92) and 0.96 (95%CI: 0.92; 1.00) per 1% higher FMD, respectively). For studies reporting categorical risk estimates, the pooled overall CVD risk for high vs. low FMD was similar in both types of populations, on average 0.49 (95%CI: 0.39; 0.62). Conclusions Our findings show that brachial FMD is inversely associated with future CVD events, with some indications for a stronger relation in diseased populations. Endothelial dysfunction may be considered relevant for classifying subjects in terms of CVD risk. Background Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future cardiovascular disease (CVD). The predictive strength of FMD in CVD patients compared to populations not diagnosed for CVD warrants further investigation. We systematically reviewed prospective studies that investigated the association between brachial FMD and future cardiovascular events, with particular focus on the role of underlying health status. Methods To obtain eligible studies, several literature databases were systematically searched through March 2011. Pooled overall risk estimates were calculated separately for continuous risk estimates for CVD (per 1% higher FMD) and for categorical risk estimates for CVD (having high vs. low FMD), based on random-effects models. Results A total of 23 studies including 14,753 subjects were eligible for inclusion in the meta-analysis. For studies reporting continuous risk estimates, the pooled overall CVD risk was 0.92 (95%CI: 0.88; 0.95) per 1% higher FMD. The observed association seemed stronger (P-value <0.01) in diseased populations than in asymptomatic populations (0.87 (95%CI: 0.83; 0.92) and 0.96 (95%CI: 0.92; 1.00) per 1% higher FMD, respectively). For studies reporting categorical risk estimates, the pooled overall CVD risk for high vs. low FMD was similar in both types of populations, on average 0.49 (95%CI: 0.39; 0.62). Conclusions Our findings show that brachial FMD is inversely associated with future CVD events, with some indications for a stronger relation in diseased populations. Endothelial dysfunction may be considered relevant for classifying subjects in terms of CVD risk. Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future cardiovascular disease (CVD). The predictive strength of FMD in CVD patients compared to populations not diagnosed for CVD warrants further investigation. We systematically reviewed prospective studies that investigated the association between brachial FMD and future cardiovascular events, with particular focus on the role of underlying health status. To obtain eligible studies, several literature databases were systematically searched through March 2011. Pooled overall risk estimates were calculated separately for continuous risk estimates for CVD (per 1% higher FMD) and for categorical risk estimates for CVD (having high vs. low FMD), based on random-effects models. A total of 23 studies including 14,753 subjects were eligible for inclusion in the meta-analysis. For studies reporting continuous risk estimates, the pooled overall CVD risk was 0.92 (95%CI: 0.88; 0.95) per 1% higher FMD. The observed association seemed stronger (P-value<0.01) in diseased populations than in asymptomatic populations (0.87 (95%CI: 0.83; 0.92) and 0.96 (95%CI: 0.92; 1.00) per 1% higher FMD, respectively). For studies reporting categorical risk estimates, the pooled overall CVD risk for high vs. low FMD was similar in both types of populations, on average 0.49 (95%CI: 0.39; 0.62). Our findings show that brachial FMD is inversely associated with future CVD events, with some indications for a stronger relation in diseased populations. Endothelial dysfunction may be considered relevant for classifying subjects in terms of CVD risk. |
| Author | Streppel, Martinette T. Draijer, Richard Ras, Rouyanne T. Zock, Peter L. |
| Author_xml | – sequence: 1 givenname: Rouyanne T. surname: Ras fullname: Ras, Rouyanne T. email: Rouyanne.Ras@unilever.com organization: Nutrition and Health Department, Unilever R&D Vlaardingen, The Netherlands – sequence: 2 givenname: Martinette T. surname: Streppel fullname: Streppel, Martinette T. organization: Division of Human Nutrition, Wageningen University, The Netherlands – sequence: 3 givenname: Richard surname: Draijer fullname: Draijer, Richard organization: Nutrition and Health Department, Unilever R&D Vlaardingen, The Netherlands – sequence: 4 givenname: Peter L. surname: Zock fullname: Zock, Peter L. organization: Nutrition and Health Department, Unilever R&D Vlaardingen, The Netherlands |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27757740$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23041097$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVklFrFDEUhYNU7Lb6D0TmRfBlxiSTmSRFhFKsCgUf1OeQydzVbLOZNZnpsP_eO-5WQZDiSwLhfCc35-SMnMQhAiHPGa0YZe3rTeU3zqa-4pTxiuqKCvmIrJiSomSyESdkhTJZNlzWp-Qs5w2lVGitnpBTXlPBqJYrYq_DMJdb6L0doS96H-zoh1jY2BeLux_ubHZTsKlIPt8Wu4RSt0guissi7_MIWyRckeDOw1zMfvxebGG0pY027LPPT8njtQ0Znh33c_L1-t2Xqw_lzaf3H68ub0rXNGwsrWw416Lvaa26tlm3VHfA8cwpnLljXDgHaxBWKFCu7UTHtdRKONpJ3aiuPicXB9_ZfoPoIy4m2uR8NoP1Jvgu2bQ385RMDMu2m7psRN0oRRF-dYB3afgxQR7N1mcHIdgIw5QNEzXjWrWCo_TFUTp1mJvZJb9djO8zRcHLowCTs2GdbFyG-K2TspFS0D8DuzTknGBtnB9_pT8m64Nh1CxFm405FG2Wog3VBotGWPwF3_s_gL09YIBNYGHJZOchOiw1gRtNP_j_NXDBR4_vvIU95M0wJewdAzMZGfN5-YLLD2Rowppao8Gbfxs8fP9Prnru1w |
| CODEN | IJCDD5 |
| CitedBy_id | crossref_primary_10_3389_fcvm_2022_833125 crossref_primary_10_1111_cpf_12399 crossref_primary_10_3389_fendo_2021_731273 crossref_primary_10_3945_jn_117_250225 crossref_primary_10_1016_j_atherosclerosis_2018_02_030 crossref_primary_10_1016_j_mvr_2019_103914 crossref_primary_10_1161_STROKEAHA_117_019476 crossref_primary_10_1016_j_nutres_2023_09_007 crossref_primary_10_3389_fnut_2022_1077534 crossref_primary_10_1016_j_ejim_2016_09_008 crossref_primary_10_3389_fcimb_2021_618265 crossref_primary_10_3389_fcvm_2023_1206156 crossref_primary_10_1016_j_mvr_2017_11_001 crossref_primary_10_17816_CS625805 crossref_primary_10_25259_AJBPS_6_2024 crossref_primary_10_1016_j_cpcardiol_2023_101748 crossref_primary_10_1016_j_rmed_2020_106173 crossref_primary_10_1016_j_abb_2018_05_016 crossref_primary_10_3945_ajcn_114_097089 crossref_primary_10_1016_j_jss_2017_11_062 crossref_primary_10_1161_ATVBAHA_114_304699 crossref_primary_10_3390_nu15132949 crossref_primary_10_1152_ajpregu_00143_2018 crossref_primary_10_1097_HJH_0000000000000926 crossref_primary_10_1093_advances_nmz105 crossref_primary_10_14814_phy2_14369 crossref_primary_10_23736_S0022_4707_20_10681_9 crossref_primary_10_1017_jns_2016_40 crossref_primary_10_1093_ajcn_nqx046 crossref_primary_10_3390_ijms22052419 crossref_primary_10_1177_2047487314558377 crossref_primary_10_7863_ultra_16_02071 crossref_primary_10_1016_j_atherosclerosis_2018_06_865 crossref_primary_10_1097_PSY_0000000000001039 crossref_primary_10_1016_j_archger_2024_105624 crossref_primary_10_1113_EP085367 crossref_primary_10_1016_j_ekir_2021_06_006 crossref_primary_10_1177_0333102416631961 crossref_primary_10_3389_fmed_2022_864185 crossref_primary_10_1038_jes_2014_93 crossref_primary_10_1152_physiolgenomics_00054_2016 crossref_primary_10_2174_1573402117666210218105951 crossref_primary_10_1186_s40798_024_00734_4 crossref_primary_10_1194_jlr_M067801 crossref_primary_10_1002_uog_26182 crossref_primary_10_3345_cep_2020_00997 crossref_primary_10_1108_NFS_08_2018_0245 crossref_primary_10_1017_S0954422421000378 crossref_primary_10_1152_ajpheart_00307_2020 crossref_primary_10_1007_s40279_020_01325_5 crossref_primary_10_1016_j_clnu_2020_09_041 crossref_primary_10_3390_jcm9082487 crossref_primary_10_3389_fphys_2021_803102 crossref_primary_10_1177_17085381231175707 crossref_primary_10_3389_fphys_2023_1043108 crossref_primary_10_14814_phy2_15395 crossref_primary_10_1097_FJC_0000000000000757 crossref_primary_10_1016_j_jstrokecerebrovasdis_2019_104489 crossref_primary_10_4236_ojemd_2021_111004 crossref_primary_10_3390_jcm11236962 crossref_primary_10_1007_s00394_020_02340_y crossref_primary_10_1007_s11739_017_1690_0 crossref_primary_10_2174_1381612826666200417153241 crossref_primary_10_1007_s11936_021_00913_6 crossref_primary_10_1902_jop_2017_170023 crossref_primary_10_3233_CH_168102 crossref_primary_10_1155_2019_7092151 crossref_primary_10_3389_fphys_2024_1411277 crossref_primary_10_1016_j_mvr_2020_104008 crossref_primary_10_1093_ajh_hpz126 crossref_primary_10_1007_s40121_016_0115_0 crossref_primary_10_1093_ajh_hpx060 crossref_primary_10_1161_CIRCIMAGING_116_004182 crossref_primary_10_1111_resp_12946 crossref_primary_10_1161_ATVBAHA_119_312682 crossref_primary_10_1152_ajpheart_00373_2024 crossref_primary_10_3389_fphys_2019_00638 crossref_primary_10_1155_2018_7926473 crossref_primary_10_1016_j_healun_2015_03_004 crossref_primary_10_5534_wjmh_230192 crossref_primary_10_1161_HYPERTENSIONAHA_120_16411 crossref_primary_10_1097_MCA_0000000000000178 crossref_primary_10_1249_JES_0000000000000293 crossref_primary_10_1016_j_jcf_2025_02_001 crossref_primary_10_1136_bmjopen_2020_043060 crossref_primary_10_1038_hr_2015_59 crossref_primary_10_1113_EP085566 crossref_primary_10_1016_j_clnu_2020_09_015 crossref_primary_10_1021_jf501611w crossref_primary_10_1002_JPER_24_0422 crossref_primary_10_1016_j_bbih_2022_100527 crossref_primary_10_1016_j_heliyon_2024_e34588 crossref_primary_10_1055_a_2266_1503 crossref_primary_10_1007_s13668_020_00328_y crossref_primary_10_1016_j_jaci_2019_05_037 crossref_primary_10_3945_ajcn_113_058313 crossref_primary_10_1016_j_maturitas_2023_01_006 crossref_primary_10_1038_bjc_2015_479 crossref_primary_10_1111_eci_14376 crossref_primary_10_1017_S0954422418000033 crossref_primary_10_5551_jat_41335 crossref_primary_10_1016_j_amjmed_2015_08_038 crossref_primary_10_1016_j_ijcard_2014_12_072 crossref_primary_10_1016_j_ejphar_2017_04_015 crossref_primary_10_1161_JAHA_124_034683 crossref_primary_10_1093_ehjci_jet256 crossref_primary_10_1111_ijcp_12630 crossref_primary_10_1038_s41440_023_01354_3 crossref_primary_10_1186_s13098_019_0457_3 crossref_primary_10_1161_JAHA_121_020980 crossref_primary_10_1093_jn_nxaa158 crossref_primary_10_1002_pri_1820 crossref_primary_10_3390_biomedicines9060614 crossref_primary_10_1177_1535370214556948 crossref_primary_10_1038_s41598_020_80601_w crossref_primary_10_1093_humrep_dez104 crossref_primary_10_1016_j_clnu_2022_03_014 crossref_primary_10_1038_s41598_023_49122_0 crossref_primary_10_1210_clinem_dgad175 crossref_primary_10_4254_wjh_v7_i27_2703 crossref_primary_10_1007_s12020_020_02596_8 crossref_primary_10_1016_j_thromres_2020_07_049 crossref_primary_10_3945_an_115_010397 crossref_primary_10_3390_biomedicines9020122 crossref_primary_10_1586_14779072_2014_909728 crossref_primary_10_1007_s11764_023_01372_7 crossref_primary_10_1039_D3FO00157A crossref_primary_10_1117_1_BIOS_1_2_025004 crossref_primary_10_1016_j_exger_2021_111515 crossref_primary_10_1186_s12872_022_02898_x crossref_primary_10_1113_EP090340 crossref_primary_10_1038_s41598_020_64365_x crossref_primary_10_36290_int_2019_014 crossref_primary_10_1186_s12933_018_0797_6 crossref_primary_10_1186_s12872_021_01849_2 crossref_primary_10_1016_j_rmed_2016_12_004 crossref_primary_10_1016_j_dhjo_2021_101112 crossref_primary_10_4239_wjd_v10_i2_63 crossref_primary_10_7197_cmj_874258 crossref_primary_10_1007_s11739_016_1409_7 crossref_primary_10_1161_JAHA_117_008273 crossref_primary_10_1039_C6FO00639F crossref_primary_10_1155_2018_3104945 crossref_primary_10_1161_JAHA_116_003202 crossref_primary_10_3390_ijms241310705 crossref_primary_10_1152_japplphysiol_00354_2014 crossref_primary_10_1016_j_ijcard_2013_12_264 crossref_primary_10_1016_j_atherosclerosis_2016_07_908 crossref_primary_10_1161_JAHA_118_010994 crossref_primary_10_1007_s11357_020_00312_y crossref_primary_10_1152_ajpheart_00345_2018 crossref_primary_10_3389_fphys_2022_967478 crossref_primary_10_1161_JAHA_113_000426 crossref_primary_10_1161_HYPERTENSIONAHA_120_15754 crossref_primary_10_3390_nu15112618 crossref_primary_10_2174_0115734021280797240212091416 crossref_primary_10_3390_ijerph18158169 crossref_primary_10_1093_ajh_hpz061 crossref_primary_10_3390_biomedicines13020381 crossref_primary_10_3390_cells12040584 crossref_primary_10_1016_j_atherosclerosis_2016_03_011 crossref_primary_10_1590_1806_9282_20240517 crossref_primary_10_3390_nu15071557 crossref_primary_10_1080_15569527_2018_1504056 crossref_primary_10_1093_ajh_hpab146 crossref_primary_10_1016_j_ahj_2016_05_008 crossref_primary_10_1016_j_jdiacomp_2020_107609 crossref_primary_10_1038_s41598_017_00205_9 crossref_primary_10_1016_j_msard_2023_104936 crossref_primary_10_2147_NSS_S329359 crossref_primary_10_3390_nu11030640 crossref_primary_10_1093_cvr_cvac095 crossref_primary_10_1152_ajpheart_00342_2020 crossref_primary_10_1016_j_cjca_2022_04_011 crossref_primary_10_1177_00033197241263384 crossref_primary_10_1177_2047487318800072 crossref_primary_10_1016_j_socscimed_2023_115673 crossref_primary_10_1001_jamacardio_2019_3252 crossref_primary_10_1002_ptr_8109 crossref_primary_10_1016_j_soard_2023_05_010 crossref_primary_10_1016_j_ijcard_2020_08_038 crossref_primary_10_3390_nu17010058 crossref_primary_10_1017_S0007114515002986 crossref_primary_10_1080_00207144_2016_1171093 crossref_primary_10_1155_2017_9632846 crossref_primary_10_1055_a_1717_1798 crossref_primary_10_17706_ijbbb_2018_8_3_147_154 crossref_primary_10_1111_1755_5922_12215 crossref_primary_10_1371_journal_pone_0257607 crossref_primary_10_1002_14651858_CD013617 crossref_primary_10_1177_00033197211072598 crossref_primary_10_1007_s40520_015_0377_5 crossref_primary_10_1002_ptr_7000 crossref_primary_10_1177_1932296821993178 crossref_primary_10_36290_far_2016_018 crossref_primary_10_1113_EP087499 crossref_primary_10_1093_nutrit_nuy032 crossref_primary_10_1024_0301_1526_a000963 crossref_primary_10_1152_japplphysiol_00308_2023 crossref_primary_10_5551_jat_42150 crossref_primary_10_1002_dmrr_3600 crossref_primary_10_1161_CIRCULATIONAHA_116_022194 crossref_primary_10_3390_nu6125772 crossref_primary_10_1007_s00421_022_05102_2 crossref_primary_10_1007_s12265_023_10451_0 crossref_primary_10_1093_bbb_zbab186 crossref_primary_10_3389_fcvm_2022_935810 crossref_primary_10_1161_JAHA_118_008588 crossref_primary_10_1016_j_mad_2016_02_007 crossref_primary_10_1113_EP090749 crossref_primary_10_1155_2021_1061800 crossref_primary_10_1038_s41598_017_02384_x crossref_primary_10_1093_ajcn_nqz075 crossref_primary_10_3389_fcvm_2022_911603 crossref_primary_10_1038_hr_2015_4 crossref_primary_10_1042_CS20190488 crossref_primary_10_1007_s00392_014_0782_3 crossref_primary_10_1161_JAHA_115_003010 crossref_primary_10_3390_nu13072436 crossref_primary_10_3390_nu12051404 crossref_primary_10_1093_eurheartj_ehz350 crossref_primary_10_1002_mnfr_201700645 crossref_primary_10_1080_02640414_2022_2091347 crossref_primary_10_1093_nutrit_nuy005 crossref_primary_10_1113_JP274372 crossref_primary_10_1093_eurheartj_ehx177 crossref_primary_10_1093_eurheartj_ehz114 crossref_primary_10_1161_HYPERTENSIONAHA_119_12881 crossref_primary_10_1161_HYPERTENSIONAHA_123_21230 crossref_primary_10_1016_j_nut_2016_07_017 crossref_primary_10_1016_j_ijsu_2019_01_014 crossref_primary_10_1016_j_conctc_2017_05_004 crossref_primary_10_1161_JAHA_115_002270 crossref_primary_10_1097_CRD_0000000000000383 crossref_primary_10_1155_2022_2432567 crossref_primary_10_1016_j_atherosclerosis_2022_03_030 crossref_primary_10_1016_j_fertnstert_2016_01_024 crossref_primary_10_1016_j_amjmed_2023_09_013 crossref_primary_10_1016_j_amjcard_2021_11_003 crossref_primary_10_1080_17476348_2023_2176845 crossref_primary_10_1016_j_atherosclerosis_2016_10_027 crossref_primary_10_3389_fphys_2019_00264 crossref_primary_10_1016_j_mvr_2018_01_004 crossref_primary_10_3389_fsurg_2022_967785 crossref_primary_10_1007_s12011_021_02789_w crossref_primary_10_1080_17476348_2017_1389277 crossref_primary_10_1016_j_phrs_2016_06_011 crossref_primary_10_1093_ofid_ofaa280 crossref_primary_10_1088_1361_6579_aac7ac crossref_primary_10_3390_physiologia4030015 crossref_primary_10_3389_fphys_2022_966561 crossref_primary_10_1017_S0007114515002822 crossref_primary_10_1007_s00592_023_02228_3 crossref_primary_10_1002_dmrr_3215 crossref_primary_10_1161_HYPERTENSIONAHA_119_12780 crossref_primary_10_3390_biomedicines10040916 crossref_primary_10_3390_ijerph18136723 crossref_primary_10_1007_s00394_018_1612_6 crossref_primary_10_1002_ptr_7441 crossref_primary_10_1089_ars_2022_0087 crossref_primary_10_1093_ehjopen_oeae098 crossref_primary_10_1097_CRD_0000000000000442 crossref_primary_10_1016_j_ajcnut_2023_03_017 crossref_primary_10_1152_japplphysiol_00063_2023 crossref_primary_10_1055_s_0040_1721694 crossref_primary_10_1017_S0007114521004803 crossref_primary_10_1186_s13643_022_02036_w crossref_primary_10_3390_ijms23020912 crossref_primary_10_1007_s40618_023_02183_4 crossref_primary_10_1016_j_atherosclerosis_2024_117504 crossref_primary_10_1152_ajpheart_00570_2024 crossref_primary_10_1161_ATVBAHA_118_311455 crossref_primary_10_1017_jns_2021_73 crossref_primary_10_1093_nutrit_nuu014 crossref_primary_10_1016_j_berh_2019_01_002 crossref_primary_10_3945_an_115_011619 crossref_primary_10_1113_EP090396 crossref_primary_10_2174_1570161116666181005122339 crossref_primary_10_1177_1358863X15611225 crossref_primary_10_2215_CJN_02020220 crossref_primary_10_1016_j_cjca_2024_10_021 crossref_primary_10_1016_j_ijcard_2016_11_025 crossref_primary_10_1161_JAHA_123_029662 crossref_primary_10_3390_biomedicines11051312 crossref_primary_10_3390_biomedicines11082174 crossref_primary_10_1002_mnfr_201600250 crossref_primary_10_1097_GME_0000000000000405 crossref_primary_10_1016_j_acmx_2016_03_001 crossref_primary_10_1007_s40292_019_00355_z crossref_primary_10_3109_14767058_2014_906574 crossref_primary_10_1111_jog_15092 crossref_primary_10_1186_s12871_021_01400_y crossref_primary_10_1080_14779072_2019_1598262 crossref_primary_10_1161_HYPERTENSIONAHA_116_07698 crossref_primary_10_3390_biomedicines12112595 crossref_primary_10_3389_fmed_2021_669397 crossref_primary_10_1139_apnm_2020_0704 crossref_primary_10_1097_HJH_0000000000002870 crossref_primary_10_3390_life11020128 crossref_primary_10_1016_j_mvr_2023_104536 crossref_primary_10_1007_s00380_018_1265_7 crossref_primary_10_1016_j_msard_2024_105902 crossref_primary_10_1007_s40279_018_0885_5 crossref_primary_10_1136_heartjnl_2020_318150 crossref_primary_10_3945_ajcn_114_102053 crossref_primary_10_1080_07853890_2016_1252055 crossref_primary_10_1002_ptr_7659 crossref_primary_10_1016_j_pcad_2016_09_006 crossref_primary_10_3390_ijms21041477 crossref_primary_10_1016_j_cjca_2021_09_003 crossref_primary_10_1136_openhrt_2014_000113 crossref_primary_10_1007_s00421_018_3876_1 crossref_primary_10_1016_j_jash_2018_09_009 crossref_primary_10_1161_HYPERTENSIONAHA_121_17622 crossref_primary_10_1007_s40279_023_01837_w crossref_primary_10_1097_MD_0000000000000073 crossref_primary_10_3389_fphys_2022_980783 crossref_primary_10_1016_j_numecd_2023_09_015 crossref_primary_10_1016_j_ijcard_2016_01_200 crossref_primary_10_1161_HYPERTENSIONAHA_119_13676 crossref_primary_10_3390_biom10040641 crossref_primary_10_1007_s11906_014_0514_0 crossref_primary_10_1039_C9FO02291K crossref_primary_10_1007_s10554_021_02293_1 crossref_primary_10_1038_s41598_018_22897_3 crossref_primary_10_1097_HJH_0000000000003980 crossref_primary_10_3945_ajcn_116_136960 crossref_primary_10_1161_JAHA_120_016625 crossref_primary_10_1007_s11883_014_0427_z crossref_primary_10_1093_ajcn_nqac153 crossref_primary_10_1155_2015_728127 crossref_primary_10_14814_phy2_14872 crossref_primary_10_3389_fcvm_2019_00166 crossref_primary_10_3389_fphys_2024_1349313 crossref_primary_10_1016_j_hlc_2018_09_006 crossref_primary_10_1039_D0FO00537A crossref_primary_10_3349_ymj_2016_57_6_1446 crossref_primary_10_3390_ijerph19020904 crossref_primary_10_1016_j_joen_2019_03_003 crossref_primary_10_1111_jfbc_12557 crossref_primary_10_1016_j_ejim_2015_10_016 crossref_primary_10_1177_00033197211010096 crossref_primary_10_1016_j_ijcha_2022_100960 crossref_primary_10_1038_hr_2016_152 crossref_primary_10_1371_journal_pone_0130913 crossref_primary_10_1002_jcsm_13471 crossref_primary_10_3390_Obesities1010006 crossref_primary_10_3389_fphys_2020_00348 crossref_primary_10_3389_fphys_2016_00571 crossref_primary_10_3945_ajcn_115_128819 crossref_primary_10_1039_C9FO01747J crossref_primary_10_1016_j_yjmcc_2020_04_020 crossref_primary_10_1016_j_ijcha_2020_100632 crossref_primary_10_1152_physrev_00014_2016 crossref_primary_10_1152_ajpregu_00274_2020 crossref_primary_10_1111_eci_13552 crossref_primary_10_1089_ars_2014_6158 crossref_primary_10_1080_14779072_2020_1767594 crossref_primary_10_1093_ajcn_nqaa312 crossref_primary_10_1016_j_ijcard_2017_01_072 crossref_primary_10_3945_ajcn_116_137919 crossref_primary_10_1089_ham_2022_0107 crossref_primary_10_1097_HCO_0000000000000630 crossref_primary_10_3390_nu14163404 crossref_primary_10_1016_j_jand_2019_03_016 crossref_primary_10_3390_ijms160715918 crossref_primary_10_1002_jmv_24784 crossref_primary_10_1542_peds_2015_0616 crossref_primary_10_1016_j_freeradbiomed_2020_02_026 crossref_primary_10_1007_s00394_016_1341_7 crossref_primary_10_1016_j_nut_2019_110594 crossref_primary_10_1253_circj_CJ_15_0068 crossref_primary_10_1161_CIRCULATIONAHA_121_055329 crossref_primary_10_1007_s00380_014_0475_x crossref_primary_10_4163_jnh_2014_47_4_236 crossref_primary_10_3390_nu14142955 crossref_primary_10_1016_j_prrv_2020_05_007 crossref_primary_10_1002_tsm2_254 crossref_primary_10_1093_pm_pnz223 crossref_primary_10_1097_HCR_0000000000000805 crossref_primary_10_3390_ijerph20196864 crossref_primary_10_1080_08923973_2016_1247855 crossref_primary_10_1007_s11739_019_02163_8 crossref_primary_10_1016_j_atherosclerosis_2015_05_007 crossref_primary_10_1152_ajpheart_00615_2020 crossref_primary_10_1101_cshperspect_a029819 crossref_primary_10_1113_JP270597 crossref_primary_10_1152_ajpheart_00815_2024 crossref_primary_10_1111_bph_13517 crossref_primary_10_1161_HYPERTENSIONAHA_115_06554 crossref_primary_10_1016_j_atherosclerosis_2014_12_056 crossref_primary_10_1093_ajcn_nqab428 crossref_primary_10_1161_JAHA_114_001472 crossref_primary_10_23736_S0392_9590_18_03983_4 crossref_primary_10_1016_j_freeradbiomed_2013_09_016 crossref_primary_10_3390_antiox9050390 crossref_primary_10_1146_annurev_nutr_071714_034449 crossref_primary_10_1080_15284336_2018_1455366 crossref_primary_10_1093_advances_nmac105 crossref_primary_10_3389_fcvm_2022_870847 crossref_primary_10_1161_JAHA_124_037731 crossref_primary_10_1016_j_ijcard_2018_02_064 crossref_primary_10_1097_MBP_0000000000000490 crossref_primary_10_1002_cre2_630 crossref_primary_10_1111_odi_12909 crossref_primary_10_1042_BSR20180732 crossref_primary_10_1016_j_jacc_2019_09_067 crossref_primary_10_1016_j_freeradbiomed_2014_04_006 crossref_primary_10_1016_j_phrs_2021_105511 crossref_primary_10_1113_JP282766 crossref_primary_10_1097_GME_0000000000002000 crossref_primary_10_3390_nu11010116 crossref_primary_10_1093_eurheartj_ehz923 crossref_primary_10_1155_2016_4613202 crossref_primary_10_1186_s12882_019_1484_x crossref_primary_10_1016_j_orcp_2024_11_004 crossref_primary_10_3390_nu14112263 crossref_primary_10_1152_ajpheart_00823_2016 crossref_primary_10_1186_s13063_017_2179_x crossref_primary_10_1097_HJH_0000000000001012 crossref_primary_10_1016_j_pcad_2014_10_004 crossref_primary_10_20945_2359_3997000000298 crossref_primary_10_1016_j_placenta_2020_06_015 crossref_primary_10_3390_ijerph15061166 crossref_primary_10_1186_s13075_015_0795_y crossref_primary_10_3945_ajcn_116_143552 crossref_primary_10_1152_ajpregu_00168_2023 crossref_primary_10_14814_phy2_15896 crossref_primary_10_1002_jsfa_11294 crossref_primary_10_1016_j_atherosclerosis_2020_04_009 crossref_primary_10_5551_jat_39446 crossref_primary_10_1002_clc_22534 crossref_primary_10_1113_JP281698 crossref_primary_10_1161_CIRCRESAHA_124_323975 crossref_primary_10_1007_s00380_019_01371_8 crossref_primary_10_1113_JP280369 crossref_primary_10_1249_MSS_0000000000000341 crossref_primary_10_1016_j_maturitas_2024_107940 crossref_primary_10_1007_s11906_017_0717_2 crossref_primary_10_1016_j_nutres_2024_03_010 crossref_primary_10_3390_v14122676 crossref_primary_10_1007_s10865_016_9742_x crossref_primary_10_3390_diagnostics14222499 crossref_primary_10_1177_0003319720903586 crossref_primary_10_1016_j_ijcard_2016_06_164 crossref_primary_10_1002_jcph_976 crossref_primary_10_1002_mnfr_202100990 crossref_primary_10_1007_s40279_019_01055_3 crossref_primary_10_1093_eurheartj_ehab222 crossref_primary_10_1177_1933719117728797 crossref_primary_10_1111_ctr_13352 crossref_primary_10_1007_s12350_023_03200_y crossref_primary_10_1016_j_trsl_2021_03_016 crossref_primary_10_5312_wjo_v5_i3_328 crossref_primary_10_1182_blood_2023022192 |
| Cites_doi | 10.1161/01.ATV.0000051384.43104.FC 10.1097/MCA.0b013e32832e5c61 10.2169/internalmedicine.45.1534 10.1136/bmj.315.7109.629 10.1161/CIRCULATIONAHA.109.864801 10.1016/0197-2456(86)90046-2 10.1016/j.jacc.2008.08.074 10.1291/hypres.31.2105 10.1016/j.jacc.2007.11.044 10.1016/j.ijcard.2006.07.069 10.1161/CIRCULATIONAHA.106.678276 10.1097/MCA.0b013e3282f3fbde 10.1177/1358863x06075006 10.1093/ndt/gfr081 10.1016/S0002-9149(00)00857-2 10.1097/MCA.0b013e328301ba8e 10.1136/bmj.327.7414.557 10.1093/eurjhf/hfp053 10.1007/s10554-010-9616-1 10.1002/sim.1186 10.2307/3001666 10.1016/S0735-1097(01)01746-6 10.1016/j.jacc.2003.09.042 10.1016/j.ahj.2008.02.022 10.1016/S0735-1097(02)01976-9 10.1161/CIRCULATIONAHA.110.984047 10.1016/0140-6736(92)93147-F 10.1016/j.ijcard.2011.01.059 10.1016/j.jacc.2005.05.070 10.1186/1476-7120-6-61 10.1016/j.amjcard.2006.06.043 10.1161/01.CIR.0000028581.07992.56 10.1097/HJH.0b013e328304b083 10.1161/01.CIR.0000153349.77489.CF 10.1016/S0735-1097(03)00994-X 10.1016/S0735-1097(03)00333-4 10.1161/CIRCULATIONAHA.110.953653 10.1080/00365510902745378 10.1161/01.CIR.0000095273.92468.D9 10.5551/jat.5181 10.1056/NEJM199901143400207 10.1001/jama.280.19.1690 10.1016/j.ijcard.2008.01.021 10.1136/jech.52.6.377 10.1152/ajpheart.00471.2010 10.1016/S0735-1097(03)00927-6 10.1002/clc.20314 |
| ContentType | Journal Article |
| Copyright | 2012 Elsevier Ireland Ltd Elsevier Ireland Ltd 2014 INIST-CNRS Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. Wageningen University & Research |
| Copyright_xml | – notice: 2012 Elsevier Ireland Ltd – notice: Elsevier Ireland Ltd – notice: 2014 INIST-CNRS – notice: Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. – notice: Wageningen University & Research |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 QVL |
| DOI | 10.1016/j.ijcard.2012.09.047 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic NARCIS:Publications |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1874-1754 |
| EndPage | 351 |
| ExternalDocumentID | oai_library_wur_nl_wurpubs_435880 23041097 27757740 10_1016_j_ijcard_2012_09_047 S0167527312011539 1_s2_0_S0167527312011539 |
| Genre | Meta-Analysis Systematic Review Journal Article |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRHN AFTJW AFXIZ AGCQF AGUBO AGYEJ AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM M29 M41 MO0 N9A O-L O9- OA. OAUVE OL~ OZT P-8 P-9 P2P PC. Q38 ROL RPZ SAE SCC SDF SDG SEL SES SPCBC SSH SSZ T5K UV1 Z5R ~G- .55 .GJ 0SF 29J AACTN AAQXK ACRPL ADMUD ADNMO ADVLN AFCTW AFFNX AFJKZ AFKWA AGHFR AHHHB AJOXV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 HEB HMK HMO HVGLF HZ~ NCXOZ R2- RIG SEW WUQ X7M ZGI AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR ZA5 AAYWO AAYXX AGQPQ AGRNS AIGII APXCP CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 - 0R 1 1P 55 8P ABFLS ABPTK ADALY ADBIT AFRUD FO G- GJ HZ K M OL QVL UNR |
| ID | FETCH-LOGICAL-c551t-a752294dd038b65f609be2522c8998b124ccefe4a48e8c6b4b297984c0b7958b3 |
| IEDL.DBID | AIKHN |
| ISSN | 0167-5273 1874-1754 |
| IngestDate | Tue Jan 05 18:02:28 EST 2021 Fri Sep 05 09:23:32 EDT 2025 Mon Jul 21 05:31:58 EDT 2025 Wed Apr 02 07:14:58 EDT 2025 Tue Jul 01 04:30:56 EDT 2025 Thu Apr 24 23:04:32 EDT 2025 Fri Feb 23 02:34:51 EST 2024 Sun Feb 23 10:20:23 EST 2025 Tue Aug 26 20:02:04 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Cardiovascular disease Flow-mediated dilation Endothelial function Prospective studies Meta-analysis Evidence-based practice Prediction Systematic review Evidence-based medicine Metaanalysis Vascular disease Prospective Atherosclerosis Risk factor Cardiovascular risk Cardiology Predictive factor |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c551t-a752294dd038b65f609be2522c8998b124ccefe4a48e8c6b4b297984c0b7958b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
| PMID | 23041097 |
| PQID | 1431298642 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | wageningen_narcis_oai_library_wur_nl_wurpubs_435880 proquest_miscellaneous_1431298642 pubmed_primary_23041097 pascalfrancis_primary_27757740 crossref_citationtrail_10_1016_j_ijcard_2012_09_047 crossref_primary_10_1016_j_ijcard_2012_09_047 elsevier_sciencedirect_doi_10_1016_j_ijcard_2012_09_047 elsevier_clinicalkeyesjournals_1_s2_0_S0167527312011539 elsevier_clinicalkey_doi_10_1016_j_ijcard_2012_09_047 |
| ProviderPackageCode | CITATION AAYXX QVL |
| PublicationCentury | 2000 |
| PublicationDate | 2013-09-20 |
| PublicationDateYYYYMMDD | 2013-09-20 |
| PublicationDate_xml | – month: 09 year: 2013 text: 2013-09-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | Shannon |
| PublicationPlace_xml | – name: Shannon – name: Netherlands |
| PublicationTitle | International journal of cardiology |
| PublicationTitleAlternate | Int J Cardiol |
| PublicationYear | 2013 |
| Publisher | Elsevier Ireland Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ireland Ltd – name: Elsevier |
| References | Suzuki, Hirata, Elkind (bb0080) 2008; 156 Corrado, Rizzo, Coppola, Muratori, Carella, Novo (bb0150) 2008; 19 Wang, Guo, Li, Cao, Fu (bb0090) 2009; 20 Modena, Bonetti, Coppi, Bursi, Rossi (bb0210) 2002; 40 Katz, Hryniewicz, Hriljac (bb0055) 2005; 111 Hu, Wang, Lau, Tse (bb0240) 2008; 31 Neunteufl, Heher, Katzenschlager (bb0145) 2000; 86 Shechter, Issachar, Marai (bb0195) 2009; 134 Yeboah, Crouse, Hsu, Burke, Herrington (bb0200) 2007; 115 Shechter, Matetzky, Arad, Feinberg, Freimark (bb0245) 2009; 11 Gokce, Keaney, Hunter (bb0060) 2003; 41 Takase, Matsushima, Uehata, Ishihara, Kurita (bb0100) 2008; 6 Brevetti, Silvestro, Schiano, Chiariello (bb0050) 2003; 108 Fathi, Haluska, Isbel, Short, Marwick (bb0040) 2004; 43 Frick, Suessenbacher, Alber (bb0035) 2005; 46 Anderson, Charbonneau, Title (bb0075) 2011; 123 Thijssen, Black, Pyke (bb0225) 2011; 300 Ulriksen, Malmqvist, Hansen, Friberg, Jensen (bb0140) 2009; 69 Karatzis, Ikonomidis, Vamvakou (bb0235) 2006; 98 Ross (bb0010) 1999; 340 Corretti, Anderson, Benjamin (bb0030) 2002; 39 Yeboah, Folsom, Burke (bb0070) 2009; 120 Celermajer, Sorensen, Gooch (bb0025) 1992; 340 Lind, Berglund, Larsson, Sundstrom (bb0085) 2011; 123 Yoshida, Kawano, Miyamoto (bb0110) 2006; 45 Suessenbacher, Frick, Alber, Barbieri, Pachinger, Weidinger (bb0130) 2006; 11 Vita, Keaney (bb0015) 2002; 106 Inaba, Chen, Bergmann (bb0065) 2010; 26 DerSimonian, Laird (bb0165) 1986; 7 Higgins, Thompson, Deeks, Altman (bb0180) 2003; 327 Widlansky, Gokce, Keaney, Vita (bb0005) 2003; 42 Downs, Black (bb0155) 1998; 52 Inoue, Matsuoka, Higashi (bb0230) 2008; 31 Shechter, Marai, Marai (bb0115) 2007; 9 Higgins, Thompson (bb0170) 2002; 21 Egger, Davey, Schneider, Minder (bb0185) 1997; 315 Chan, Mancini, Kuramoto, Schulzer, Frohlich, Ignaszewski (bb0105) 2003; 42 Akcakoyun, Kargin, Tanalp (bb0125) 2008; 19 Cochran (bb0175) 1954; 10 Rossi, Nuzzo, Origliani, Modena (bb0135) 2008; 51 Kitta, Obata, Nakamura (bb0215) 2009; 53 Takishima, Nakamura, Hirano (bb0220) 2012; 158 Muiesan, Salvetti, Paini (bb0045) 2008; 26 Venneri, Poggianti, Jambrik, Varga, Palinkas, Picano (bb0120) 2007; 119 Zhang, Yu (bb0160) 1998; 280 Akamatsu, Sato, Goto (bb0095) 2010; 17 Yilmaz, Stenvinkel, Sonmez (bb0205) 2011; 26 Bonetti, Lerman, Lerman (bb0020) 2003; 23 Takase (10.1016/j.ijcard.2012.09.047_bb0100) 2008; 6 Suessenbacher (10.1016/j.ijcard.2012.09.047_bb0130) 2006; 11 Egger (10.1016/j.ijcard.2012.09.047_bb0185) 1997; 315 Modena (10.1016/j.ijcard.2012.09.047_bb0210) 2002; 40 Ulriksen (10.1016/j.ijcard.2012.09.047_bb0140) 2009; 69 Kitta (10.1016/j.ijcard.2012.09.047_bb0215) 2009; 53 Vita (10.1016/j.ijcard.2012.09.047_bb0015) 2002; 106 Corretti (10.1016/j.ijcard.2012.09.047_bb0030) 2002; 39 Katz (10.1016/j.ijcard.2012.09.047_bb0055) 2005; 111 Lind (10.1016/j.ijcard.2012.09.047_bb0085) 2011; 123 Rossi (10.1016/j.ijcard.2012.09.047_bb0135) 2008; 51 Widlansky (10.1016/j.ijcard.2012.09.047_bb0005) 2003; 42 Inaba (10.1016/j.ijcard.2012.09.047_bb0065) 2010; 26 Shechter (10.1016/j.ijcard.2012.09.047_bb0115) 2007; 9 Higgins (10.1016/j.ijcard.2012.09.047_bb0180) 2003; 327 Celermajer (10.1016/j.ijcard.2012.09.047_bb0025) 1992; 340 Gokce (10.1016/j.ijcard.2012.09.047_bb0060) 2003; 41 Anderson (10.1016/j.ijcard.2012.09.047_bb0075) 2011; 123 Venneri (10.1016/j.ijcard.2012.09.047_bb0120) 2007; 119 Yilmaz (10.1016/j.ijcard.2012.09.047_bb0205) 2011; 26 Inoue (10.1016/j.ijcard.2012.09.047_bb0230) 2008; 31 Frick (10.1016/j.ijcard.2012.09.047_bb0035) 2005; 46 Akcakoyun (10.1016/j.ijcard.2012.09.047_bb0125) 2008; 19 Zhang (10.1016/j.ijcard.2012.09.047_bb0160) 1998; 280 Hu (10.1016/j.ijcard.2012.09.047_bb0240) 2008; 31 Bonetti (10.1016/j.ijcard.2012.09.047_bb0020) 2003; 23 Shechter (10.1016/j.ijcard.2012.09.047_bb0195) 2009; 134 Karatzis (10.1016/j.ijcard.2012.09.047_bb0235) 2006; 98 Yeboah (10.1016/j.ijcard.2012.09.047_bb0200) 2007; 115 Takishima (10.1016/j.ijcard.2012.09.047_bb0220) 2012; 158 DerSimonian (10.1016/j.ijcard.2012.09.047_bb0165) 1986; 7 Fathi (10.1016/j.ijcard.2012.09.047_bb0040) 2004; 43 Suzuki (10.1016/j.ijcard.2012.09.047_bb0080) 2008; 156 Cochran (10.1016/j.ijcard.2012.09.047_bb0175) 1954; 10 Brevetti (10.1016/j.ijcard.2012.09.047_bb0050) 2003; 108 Higgins (10.1016/j.ijcard.2012.09.047_bb0170) 2002; 21 Ross (10.1016/j.ijcard.2012.09.047_bb0010) 1999; 340 Akamatsu (10.1016/j.ijcard.2012.09.047_bb0095) 2010; 17 Wang (10.1016/j.ijcard.2012.09.047_bb0090) 2009; 20 Muiesan (10.1016/j.ijcard.2012.09.047_bb0045) 2008; 26 Shechter (10.1016/j.ijcard.2012.09.047_bb0245) 2009; 11 Corrado (10.1016/j.ijcard.2012.09.047_bb0150) 2008; 19 Yoshida (10.1016/j.ijcard.2012.09.047_bb0110) 2006; 45 Downs (10.1016/j.ijcard.2012.09.047_bb0155) 1998; 52 Thijssen (10.1016/j.ijcard.2012.09.047_bb0225) 2011; 300 Yeboah (10.1016/j.ijcard.2012.09.047_bb0070) 2009; 120 Chan (10.1016/j.ijcard.2012.09.047_bb0105) 2003; 42 Neunteufl (10.1016/j.ijcard.2012.09.047_bb0145) 2000; 86 |
| References_xml | – volume: 156 start-page: 405 year: 2008 end-page: 410 ident: bb0080 article-title: Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS) publication-title: Am Heart J – volume: 9 start-page: 271 year: 2007 end-page: 276 ident: bb0115 article-title: The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease publication-title: Isr Med Assoc J – volume: 21 start-page: 1539 year: 2002 end-page: 1558 ident: bb0170 article-title: Quantifying heterogeneity in a meta-analysis publication-title: Stat Med – volume: 46 start-page: 1006 year: 2005 end-page: 1010 ident: bb0035 article-title: Prognostic value of brachial artery endothelial function and wall thickness publication-title: J Am Coll Cardiol – volume: 31 start-page: 2105 year: 2008 end-page: 2113 ident: bb0230 article-title: Flow-mediated vasodilation as a diagnostic modality for vascular failure publication-title: Hypertens Res – volume: 51 start-page: 997 year: 2008 end-page: 1002 ident: bb0135 article-title: Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women publication-title: J Am Coll Cardiol – volume: 134 start-page: 52 year: 2009 end-page: 58 ident: bb0195 article-title: Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease publication-title: Int J Cardiol – volume: 115 start-page: 2390 year: 2007 end-page: 2397 ident: bb0200 article-title: Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study publication-title: Circulation – volume: 98 start-page: 1424 year: 2006 end-page: 1428 ident: bb0235 article-title: Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation publication-title: Am J Cardiol – volume: 280 start-page: 1690 year: 1998 end-page: 1691 ident: bb0160 article-title: What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes publication-title: JAMA – volume: 10 start-page: 101 year: 1954 end-page: 129 ident: bb0175 article-title: The combination of estimates from different experiments publication-title: Biometrics – volume: 315 start-page: 629 year: 1997 end-page: 634 ident: bb0185 article-title: Bias in meta-analysis detected by a simple, graphical test publication-title: BMJ – volume: 43 start-page: 616 year: 2004 end-page: 623 ident: bb0040 article-title: The relative importance of vascular structure and function in predicting cardiovascular events publication-title: J Am Coll Cardiol – volume: 69 start-page: 475 year: 2009 end-page: 480 ident: bb0140 article-title: Flow-mediated dilatation has no independent prognostic effect in patients with chest pain with or without ischaemic heart disease publication-title: Scand J Clin Lab Invest – volume: 17 start-page: 1266 year: 2010 end-page: 1274 ident: bb0095 article-title: Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease publication-title: J Atheroscler Thromb – volume: 11 start-page: 588 year: 2009 end-page: 593 ident: bb0245 article-title: Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure publication-title: Eur J Heart Fail – volume: 20 start-page: 467 year: 2009 end-page: 472 ident: bb0090 article-title: Prognostic role of brachial reactivity in patients with ST myocardial infarction after percutaneous coronary intervention publication-title: Coron Artery Dis – volume: 19 start-page: 139 year: 2008 end-page: 144 ident: bb0150 article-title: Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study publication-title: Coron Artery Dis – volume: 52 start-page: 377 year: 1998 end-page: 384 ident: bb0155 article-title: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions publication-title: J Epidemiol Community Health – volume: 31 start-page: 525 year: 2008 end-page: 530 ident: bb0240 article-title: Gender differences on brachial flow-mediated dilation and carotid intima-media thickness for prediction of spontaneous cardiovascular events publication-title: Clin Cardiol – volume: 106 start-page: 640 year: 2002 end-page: 642 ident: bb0015 article-title: Endothelial function: a barometer for cardiovascular risk? publication-title: Circulation – volume: 26 start-page: 1612 year: 2008 end-page: 1618 ident: bb0045 article-title: Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients publication-title: J Hypertens – volume: 111 start-page: 310 year: 2005 end-page: 314 ident: bb0055 article-title: Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure publication-title: Circulation – volume: 42 start-page: 1149 year: 2003 end-page: 1160 ident: bb0005 article-title: The clinical implications of endothelial dysfunction publication-title: J Am Coll Cardiol – volume: 23 start-page: 168 year: 2003 end-page: 175 ident: bb0020 article-title: Endothelial dysfunction: a marker of atherosclerotic risk publication-title: Arterioscler Thromb Vasc Biol – volume: 340 start-page: 1111 year: 1992 end-page: 1115 ident: bb0025 article-title: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis publication-title: Lancet – volume: 123 start-page: 1545 year: 2011 end-page: 1551 ident: bb0085 article-title: Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease publication-title: Circulation – volume: 7 start-page: 177 year: 1986 end-page: 188 ident: bb0165 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials – volume: 45 start-page: 575 year: 2006 end-page: 579 ident: bb0110 article-title: Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease publication-title: Intern Med – volume: 11 start-page: 239 year: 2006 end-page: 244 ident: bb0130 article-title: Association of improvement of brachial artery flow-mediated vasodilation with cardiovascular events publication-title: Vasc Med – volume: 123 start-page: 163 year: 2011 end-page: 169 ident: bb0075 article-title: Microvascular function predicts cardiovascular events in primary prevention: long-term results from the firefighters and their endothelium (FATE) study publication-title: Circulation – volume: 120 start-page: 502 year: 2009 end-page: 509 ident: bb0070 article-title: Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis publication-title: Circulation – volume: 327 start-page: 557 year: 2003 end-page: 560 ident: bb0180 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ – volume: 108 start-page: 2093 year: 2003 end-page: 2098 ident: bb0050 article-title: Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index publication-title: Circulation – volume: 86 start-page: 207 year: 2000 end-page: 210 ident: bb0145 article-title: Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain publication-title: Am J Cardiol – volume: 40 start-page: 505 year: 2002 end-page: 510 ident: bb0210 article-title: Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women publication-title: J Am Coll Cardiol – volume: 53 start-page: 323 year: 2009 end-page: 330 ident: bb0215 article-title: Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease publication-title: J Am Coll Cardiol – volume: 158 start-page: 417 year: 2012 end-page: 422 ident: bb0220 article-title: Predictive value of serial assessment of endothelial function in chronic heart failure publication-title: Int J Cardiol – volume: 41 start-page: 1769 year: 2003 end-page: 1775 ident: bb0060 article-title: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease publication-title: J Am Coll Cardiol – volume: 340 start-page: 115 year: 1999 end-page: 126 ident: bb0010 article-title: Atherosclerosis: an inflammatory disease publication-title: N Engl J Med – volume: 39 start-page: 257 year: 2002 end-page: 265 ident: bb0030 article-title: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force publication-title: J Am Coll Cardiol – volume: 300 start-page: H2 year: 2011 end-page: H12 ident: bb0225 article-title: Assessment of flow-mediated dilation in humans: a methodological and physiological guideline publication-title: Am J Physiol Heart Circ Physiol – volume: 119 start-page: 109 year: 2007 end-page: 111 ident: bb0120 article-title: The elusive prognostic value of systemic endothelial function in patients with chest pain syndrome publication-title: Int J Cardiol – volume: 19 start-page: 337 year: 2008 end-page: 343 ident: bb0125 article-title: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study publication-title: Coron Artery Dis – volume: 26 start-page: 631 year: 2010 end-page: 640 ident: bb0065 article-title: Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis publication-title: Int J Cardiovasc Imaging – volume: 6 start-page: 61 year: 2008 ident: bb0100 article-title: Endothelial dysfunction, carotid artery plaque burden, and conventional exercise-induced myocardial ischemia as predictors of coronary artery disease prognosis publication-title: Cardiovasc Ultrasound – volume: 42 start-page: 1037 year: 2003 end-page: 1043 ident: bb0105 article-title: The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease publication-title: J Am Coll Cardiol – volume: 26 start-page: 3537 year: 2011 end-page: 3543 ident: bb0205 article-title: Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes publication-title: Nephrol Dial Transplant – volume: 23 start-page: 168 year: 2003 ident: 10.1016/j.ijcard.2012.09.047_bb0020 article-title: Endothelial dysfunction: a marker of atherosclerotic risk publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000051384.43104.FC – volume: 20 start-page: 467 year: 2009 ident: 10.1016/j.ijcard.2012.09.047_bb0090 article-title: Prognostic role of brachial reactivity in patients with ST myocardial infarction after percutaneous coronary intervention publication-title: Coron Artery Dis doi: 10.1097/MCA.0b013e32832e5c61 – volume: 45 start-page: 575 year: 2006 ident: 10.1016/j.ijcard.2012.09.047_bb0110 article-title: Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease publication-title: Intern Med doi: 10.2169/internalmedicine.45.1534 – volume: 315 start-page: 629 year: 1997 ident: 10.1016/j.ijcard.2012.09.047_bb0185 article-title: Bias in meta-analysis detected by a simple, graphical test publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 120 start-page: 502 year: 2009 ident: 10.1016/j.ijcard.2012.09.047_bb0070 article-title: Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.864801 – volume: 7 start-page: 177 year: 1986 ident: 10.1016/j.ijcard.2012.09.047_bb0165 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 53 start-page: 323 year: 2009 ident: 10.1016/j.ijcard.2012.09.047_bb0215 article-title: Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.08.074 – volume: 31 start-page: 2105 year: 2008 ident: 10.1016/j.ijcard.2012.09.047_bb0230 article-title: Flow-mediated vasodilation as a diagnostic modality for vascular failure publication-title: Hypertens Res doi: 10.1291/hypres.31.2105 – volume: 51 start-page: 997 year: 2008 ident: 10.1016/j.ijcard.2012.09.047_bb0135 article-title: Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.11.044 – volume: 119 start-page: 109 year: 2007 ident: 10.1016/j.ijcard.2012.09.047_bb0120 article-title: The elusive prognostic value of systemic endothelial function in patients with chest pain syndrome publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2006.07.069 – volume: 115 start-page: 2390 year: 2007 ident: 10.1016/j.ijcard.2012.09.047_bb0200 article-title: Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.678276 – volume: 19 start-page: 139 year: 2008 ident: 10.1016/j.ijcard.2012.09.047_bb0150 article-title: Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study publication-title: Coron Artery Dis doi: 10.1097/MCA.0b013e3282f3fbde – volume: 11 start-page: 239 year: 2006 ident: 10.1016/j.ijcard.2012.09.047_bb0130 article-title: Association of improvement of brachial artery flow-mediated vasodilation with cardiovascular events publication-title: Vasc Med doi: 10.1177/1358863x06075006 – volume: 26 start-page: 3537 year: 2011 ident: 10.1016/j.ijcard.2012.09.047_bb0205 article-title: Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfr081 – volume: 86 start-page: 207 year: 2000 ident: 10.1016/j.ijcard.2012.09.047_bb0145 article-title: Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain publication-title: Am J Cardiol doi: 10.1016/S0002-9149(00)00857-2 – volume: 19 start-page: 337 year: 2008 ident: 10.1016/j.ijcard.2012.09.047_bb0125 article-title: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study publication-title: Coron Artery Dis doi: 10.1097/MCA.0b013e328301ba8e – volume: 327 start-page: 557 year: 2003 ident: 10.1016/j.ijcard.2012.09.047_bb0180 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 11 start-page: 588 year: 2009 ident: 10.1016/j.ijcard.2012.09.047_bb0245 article-title: Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfp053 – volume: 26 start-page: 631 year: 2010 ident: 10.1016/j.ijcard.2012.09.047_bb0065 article-title: Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis publication-title: Int J Cardiovasc Imaging doi: 10.1007/s10554-010-9616-1 – volume: 21 start-page: 1539 year: 2002 ident: 10.1016/j.ijcard.2012.09.047_bb0170 article-title: Quantifying heterogeneity in a meta-analysis publication-title: Stat Med doi: 10.1002/sim.1186 – volume: 10 start-page: 101 year: 1954 ident: 10.1016/j.ijcard.2012.09.047_bb0175 article-title: The combination of estimates from different experiments publication-title: Biometrics doi: 10.2307/3001666 – volume: 39 start-page: 257 year: 2002 ident: 10.1016/j.ijcard.2012.09.047_bb0030 article-title: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(01)01746-6 – volume: 43 start-page: 616 year: 2004 ident: 10.1016/j.ijcard.2012.09.047_bb0040 article-title: The relative importance of vascular structure and function in predicting cardiovascular events publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2003.09.042 – volume: 156 start-page: 405 year: 2008 ident: 10.1016/j.ijcard.2012.09.047_bb0080 article-title: Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS) publication-title: Am Heart J doi: 10.1016/j.ahj.2008.02.022 – volume: 40 start-page: 505 year: 2002 ident: 10.1016/j.ijcard.2012.09.047_bb0210 article-title: Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(02)01976-9 – volume: 123 start-page: 1545 year: 2011 ident: 10.1016/j.ijcard.2012.09.047_bb0085 article-title: Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.984047 – volume: 340 start-page: 1111 year: 1992 ident: 10.1016/j.ijcard.2012.09.047_bb0025 article-title: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis publication-title: Lancet doi: 10.1016/0140-6736(92)93147-F – volume: 158 start-page: 417 year: 2012 ident: 10.1016/j.ijcard.2012.09.047_bb0220 article-title: Predictive value of serial assessment of endothelial function in chronic heart failure publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2011.01.059 – volume: 46 start-page: 1006 year: 2005 ident: 10.1016/j.ijcard.2012.09.047_bb0035 article-title: Prognostic value of brachial artery endothelial function and wall thickness publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2005.05.070 – volume: 6 start-page: 61 year: 2008 ident: 10.1016/j.ijcard.2012.09.047_bb0100 article-title: Endothelial dysfunction, carotid artery plaque burden, and conventional exercise-induced myocardial ischemia as predictors of coronary artery disease prognosis publication-title: Cardiovasc Ultrasound doi: 10.1186/1476-7120-6-61 – volume: 98 start-page: 1424 year: 2006 ident: 10.1016/j.ijcard.2012.09.047_bb0235 article-title: Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.06.043 – volume: 106 start-page: 640 year: 2002 ident: 10.1016/j.ijcard.2012.09.047_bb0015 article-title: Endothelial function: a barometer for cardiovascular risk? publication-title: Circulation doi: 10.1161/01.CIR.0000028581.07992.56 – volume: 26 start-page: 1612 year: 2008 ident: 10.1016/j.ijcard.2012.09.047_bb0045 article-title: Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients publication-title: J Hypertens doi: 10.1097/HJH.0b013e328304b083 – volume: 111 start-page: 310 year: 2005 ident: 10.1016/j.ijcard.2012.09.047_bb0055 article-title: Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure publication-title: Circulation doi: 10.1161/01.CIR.0000153349.77489.CF – volume: 42 start-page: 1149 year: 2003 ident: 10.1016/j.ijcard.2012.09.047_bb0005 article-title: The clinical implications of endothelial dysfunction publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00994-X – volume: 9 start-page: 271 year: 2007 ident: 10.1016/j.ijcard.2012.09.047_bb0115 article-title: The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease publication-title: Isr Med Assoc J – volume: 41 start-page: 1769 year: 2003 ident: 10.1016/j.ijcard.2012.09.047_bb0060 article-title: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00333-4 – volume: 123 start-page: 163 year: 2011 ident: 10.1016/j.ijcard.2012.09.047_bb0075 article-title: Microvascular function predicts cardiovascular events in primary prevention: long-term results from the firefighters and their endothelium (FATE) study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.953653 – volume: 69 start-page: 475 year: 2009 ident: 10.1016/j.ijcard.2012.09.047_bb0140 article-title: Flow-mediated dilatation has no independent prognostic effect in patients with chest pain with or without ischaemic heart disease publication-title: Scand J Clin Lab Invest doi: 10.1080/00365510902745378 – volume: 108 start-page: 2093 year: 2003 ident: 10.1016/j.ijcard.2012.09.047_bb0050 article-title: Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index publication-title: Circulation doi: 10.1161/01.CIR.0000095273.92468.D9 – volume: 17 start-page: 1266 year: 2010 ident: 10.1016/j.ijcard.2012.09.047_bb0095 article-title: Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease publication-title: J Atheroscler Thromb doi: 10.5551/jat.5181 – volume: 340 start-page: 115 year: 1999 ident: 10.1016/j.ijcard.2012.09.047_bb0010 article-title: Atherosclerosis: an inflammatory disease publication-title: N Engl J Med doi: 10.1056/NEJM199901143400207 – volume: 280 start-page: 1690 year: 1998 ident: 10.1016/j.ijcard.2012.09.047_bb0160 article-title: What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes publication-title: JAMA doi: 10.1001/jama.280.19.1690 – volume: 134 start-page: 52 year: 2009 ident: 10.1016/j.ijcard.2012.09.047_bb0195 article-title: Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2008.01.021 – volume: 52 start-page: 377 year: 1998 ident: 10.1016/j.ijcard.2012.09.047_bb0155 article-title: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions publication-title: J Epidemiol Community Health doi: 10.1136/jech.52.6.377 – volume: 300 start-page: H2 year: 2011 ident: 10.1016/j.ijcard.2012.09.047_bb0225 article-title: Assessment of flow-mediated dilation in humans: a methodological and physiological guideline publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00471.2010 – volume: 42 start-page: 1037 year: 2003 ident: 10.1016/j.ijcard.2012.09.047_bb0105 article-title: The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00927-6 – volume: 31 start-page: 525 year: 2008 ident: 10.1016/j.ijcard.2012.09.047_bb0240 article-title: Gender differences on brachial flow-mediated dilation and carotid intima-media thickness for prediction of spontaneous cardiovascular events publication-title: Clin Cardiol doi: 10.1002/clc.20314 |
| SSID | ssj0004998 |
| Score | 2.5762546 |
| SecondaryResourceType | review_article |
| Snippet | Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future cardiovascular disease... Abstract Background Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future... Background Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function and has shown to have prognostic value for future... |
| SourceID | wageningen proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 344 |
| SubjectTerms | Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Blood Flow Velocity - physiology brachial-artery Cardiology. Vascular system Cardiovascular Cardiovascular disease Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - physiopathology chest-pain chronic heart-failure coronary-artery-disease endothelial dysfunction Endothelial function events Flow-mediated dilation Heart Humans Medical sciences Meta-analysis mortality risk postmenopausal women Predictive Value of Tests prognostic role Prospective Studies Risk Factors vasodilation Vasodilation - physiology |
| Title | Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0167527312011539 https://www.clinicalkey.es/playcontent/1-s2.0-S0167527312011539 https://dx.doi.org/10.1016/j.ijcard.2012.09.047 https://www.ncbi.nlm.nih.gov/pubmed/23041097 https://www.proquest.com/docview/1431298642 http://www.narcis.nl/publication/RecordID/oai:library.wur.nl:wurpubs%2F435880 |
| Volume | 168 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_aFEbHGPtu9hE02KsXx5ZtaW-hLGQb68tW6JuQZAlSUifECXnb3947W24aFujYU8DokujudPez_bs7gE_G-8zgnUWUcSrJyWMRidLKSHNtcheXmOQatsVFPr3k36-yqyM472phiFYZYn8b05toHa4MgzaHy9ls-IsI9NQ-bEQ5LEvlMZwkmO1FD07G335ML3blkbIZidu0-CaBroKuoXnNri2agjheSdPwlOasHM5QT5a6Rr35duDFIUT6GE63GAWqpizqXpqaPIOnAV-ycbuF53Dkqhfw6Gd4g_4S9GS-2EZNvQhiTVbOWi4c01XJ7B43lRHrnC1XJEpLvrAx2_V9Zm3NC6PnuOzGrXWkQ3uTV3A5-fr7fBqFMQuRRbi0jjRqMZG8LONUmDzzeSyNS_CapXsxgwDAWucd11w4YXPDTSILKbiNTSEzYdLX0KsWlTsD5tNcem55KjRCRe9k4TH5WeNzLTJpTB_STrXKhh7kNApjrjqy2bVqDaLIICqWCg3Sh-hOatn24HhgfdZZTXX1pRgRFSaJB-SKQ3KuDse6ViNV42L1l-vdl9zz3n_4zcGeW91tMCmKDKF53IePnZ8pPPn0OkdXbrHBP4PYL6Hu-kkf3rQOuJNOY07cAlT4ziNVReOpakUdxcMzQrXdrFQ1pw_8hloheMaA_va_t_MOTpNmXojE8PseeuvVxn1A1LY2Azj-_Gc0CGfzFjFiQvg |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6FLaOMfa97KPTYK8mri3b0t5CWUjXNi9roW9CkiVIyZwQJ-Tf350tNw0LdOwpYHRJdHe6-9n-3R3AN-N9ZvDOIso4leTksYhEaWWkuTa5i0tMcg3bYpKPr_nPm-zmAE67WhiiVYbY38b0JlqHK4OgzcFiOh38IgI9tQ87oRyWpfIRHHIaat2Dw-HZ-XiyLY-UzUjcpsU3CXQVdA3Na3pr0RTE8Uqahqc0Z2V_hnq20DXqzbcDL_Yh0qdwtMEoUDVlUffS1OgFPA_4kg3bLbyEA1e9gseX4Q36a9Cj2XwTNfUiiDVZOW25cExXJbM73FRGrHO2WJIoLfnOhmzb95m1NS-MnuOy326lIx3am7yB69GPq9NxFMYsRBbh0irSqMVE8rKMU2HyzOexNC7Ba5buxQwCAGudd1xz4YTNDTeJLKTgNjaFzIRJ30KvmlfuPTCf5tJzy1OhESp6JwuPyc8an2uRSWP6kHaqVTb0IKdRGDPVkc1uVWsQRQZRsVRokD5Ed1KLtgfHA-uzzmqqqy_FiKgwSTwgV-yTc3U41rU6UTUuVn-53n3JHe_9h9883nGruw0mRZEhNI_78LXzM4Unn17n6MrN1_hnEPsl1F0_6cO71gG30mnMiVuACt96pKpoPFWtqKN4eEaoNuulqmb0gd9QKwTPGNA__Pd2vsCT8dXlhbo4m5x_hKOkmR0iMRR_gt5quXafEcGtzHE4oX8AxglE3g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flow-mediated+dilation+and+cardiovascular+risk+prediction%3A+a+systematic+review+with+meta-analysis&rft.jtitle=International+journal+of+cardiology&rft.au=Ras%2C+Rouyanne+T&rft.au=Streppel%2C+Martinette+T&rft.au=Draijer%2C+Richard&rft.au=Zock%2C+Peter+L&rft.date=2013-09-20&rft.eissn=1874-1754&rft.volume=168&rft.issue=1&rft.spage=344&rft_id=info:doi/10.1016%2Fj.ijcard.2012.09.047&rft_id=info%3Apmid%2F23041097&rft.externalDocID=23041097 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01675273%2FS0167527313X00221%2Fcov150h.gif |